Targeting the DPP-4-GLP-1 pathway improves exercise tolerance in heart failure patients: a systematic review and meta-analysis

BACKGROUND: The most significant manifestation of heart failure is exercise intolerance. This systematic review and meta-analysis was performed to investigate whether dipeptidyl peptidase-4 (DPP-4) inhibitors or glucagon-like peptide 1 receptor agonists (GLP-1 RAs), widely used anti-diabetic drugs,...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Chengcong, Huang, Ying, Zeng, Yongmei, Lu, Xiyan, Dong, Guoqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6927173/
https://www.ncbi.nlm.nih.gov/pubmed/31870322
http://dx.doi.org/10.1186/s12872-019-01275-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6927173/
https://www.ncbi.nlm.nih.gov/pubmed/31870322
http://dx.doi.org/10.1186/s12872-019-01275-5

Ejemplares similares